Methylation of adjacent CpG sites affects Sp1/Sp3 binding and activity in the p21Cip1 promoter

Molecular and Cellular Biology

Volumn 23, Issue 12, 2003, Pages 4056-4065

  Zhu, Wei Guo ^a   Srinivasan, Kanur ^a   Dai, Zunyan ^a   Duan, Wenrui ^a   Druhan, Lawrence J ^a   Ding, Haiming ^a   Yee, Lisa ^a   Villalona Calero, Miguel A ^a   Plass, Christoph ^a   Otterson, Gregory A ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; DEPSIPEPTIDE; DNA BINDING PROTEIN; ETOPOSIDE; HISTONE DEACETYLASE; LUCIFERASE; PROTEIN P21; PROTEIN P53; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3;

ARTICLE; BINDING SITE; CODON; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; FLOW CYTOMETRY; GAMMA IRRADIATION; GEL MOBILITY SHIFT ASSAY; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUNG CANCER; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION;

BASE SEQUENCE; BINDING SITES; BLOTTING, NORTHERN; CELL LINE; CELL NUCLEUS; CODON; CPG ISLANDS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DEPSIPEPTIDES; DNA METHYLATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ETOPOSIDE; FLOW CYTOMETRY; GENES, P53; HUMANS; IMMUNOBLOTTING; LUCIFERASES; LUNG; METHYLATION; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; MUTATION; PEPTIDES; PEPTIDES, CYCLIC; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; SODIUM OXYBATE; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0037642249     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.23.12.4056-4065.2003     Document Type: Article

References (56)

1. WAF1/CIP1 gene. Mol. Cell. Biol. 20:1291-1298.
2. Alland, L., R. Muhle, H. Hou, Jr., J. Potes, L. Chin, N. Schreiber-Agus, and R. A. DePinho. 1997. Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature 387:49-55.
3. Baylin, S. B., M. Esteller, M. R. Rountree, K. E. Bachman, K. Schuebel, and J. G. Herman. 2001. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum. Mol. Genet. 10:687-692.
4. Berger, S. L. 2002. Histone modifications in transcriptional regulation. Curr. Opin. Genet. Dev. 12:142-148.
5. Bird, A. 2002. DNA methylation patterns and epigenetic memory. Genes Dev. 16:6-21.
6. Bird, A. P., and A. P. Wolffe. 1999. Methylation-induced repression: belts, braces, and chromatin. Cell 99:451-454.
7. Cameron, E. E., K. E. Bachman, S. Myohanen, J. G. Herman, and S. B. Baylin. 1999. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat. Genet. 21:103-107.
8. WAF1 promoter region. Cancer Res. 60:3290-3298.
9. Clark, S. J., J. Harrison, and P. L. Molloy. 1997. Sp1 binding is inhibited by (m)Cp(m)CpG methylation. Gene 195:67-71.
10. Comb, M., and H. M. Goodman. 1990. CpG methylation inhibits proenkephalin gene expression and binding of the transcription factor AP-2. Nucleic Acids Res. 18:3975-3982.
11. Cross, S. H., J. A. Charlton, X. Nan, and A. P. Bird. 1994. Purification of CpG islands using a methylated DNA binding column. Nat. Genet. 6:236-244.
12. Dai, Z., R. R. Lakshmanan, W. G. Zhu, D. J. Smiraglia, L. J. Rush, M. C. Fruhwald, R. M. Brena, B. Li, F. A. Wright, P. Ross, G. A. Otterson, and C. Plass. 2001. Global methylation profiling of lung cancer identifies novel methylated genes. Neoplasia 3:314-323.
13. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489.
14. WAF/Cip1 by distinct mechanisms. J. Biol. Chem. 274:24250-24256.
15. Fuentes-Panana, E. M., and P. D. Ling. 1998. Characterization of the CBF2 binding site within the Epstein-Barr virus latency C promoter and its role in modulating EBNA2-mediated transactivation. J. Virol. 72:693-700.
16. Fuks, F., W. A. Burgers, A. Brehm, L. Hughes-Davies, and T. Kouzarides. 2000. DNA methyltransferase Dnmt1 associates with histone deacetylase activity. Nat. Genet. 24:88-91.
17. WAF1/CIP1 gene. Exp. Cell Res. 246:280-289.
18. Grunstein, M. 1997. Histone acetylation in chromatin structure and transcription. Nature 389:349-352.
19. Herman, J. G., J. R. Graff, S. Myohanen, B. D. Nelkin, and S. B. Baylin. 1996. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA 93:9821-9826.
20. Holler, M., G. Westin, J. Jiricny, and W. Schaffner. 1988. Sp1 transcription factor binds DNA and activates transcription even when the binding site is CpG methylated. Genes Dev. 2:1127-1135.
21. Hong, L., G. P. Schroth, H. R. Matthews, P. Yau, and E. M. Bradbury. 1993. Studies of the DNA binding properties of histone H4 amino terminus: thermal denaturation studies reveal that acetylation markedly reduces the binding constant of the H4 "tail" to DNA. J. Biol. Chem. 268:305-314.
22. Hu, Z. Z., L. Zhuang, J. Meng, and M. L. Dufau. 1998. Transcriptional regulation of the generic promoter III of the rat prolactin receptor gene by C/EBPβ and Sp1. J. Biol. Chem. 273:26225-26235.
23. Iguchi-Ariga, S. M., and W. Schaffner. 1989. CpG methylation of the cAMP-responsive enhancer/promoter sequence TGACGTCA abolishes specific factor binding as well as transcriptional activation. Genes Dev. 3:612-619.
24. Jones, P. A., and D. Takai. 2001. The role of DNA methylation in mammalian epigenetics. Science 293:1068-1070.
25. Jones, P. L., G. J. Veenstra, P. A. Wade, D. Vermaak, S. U. Kass, N. Landsberger, J. Strouboulis, and A. P. Wolffe. 1998. Methylated DNA and MeCp2 recruit histone deacetylase to repress transcription. Nat. Genet. 19:187-191.
26. Kallio, P. J., J. J. Palvimo, M. Mehto, and O. A. Janne. 1994. Analysis of androgen receptor-DNA interactions with receptor proteins produced in insect cells. J. Biol. Chem. 269:11514-11522.
27. Kitazawa, S., R. Kitazawa, and S. Maeda. 1999. Transcriptional regulation of rat cyclin D1 gene by CpG methylation status in promoter region. J. Biol. Chem. 274:28787-28793.
28. Mancini, D. N., S. M. Singh, T. K. Archer, and D. I. Rodenhiser. 1999. Site-specific DNA methylation in the neurofibromatosis (NF1) promoter interferes with binding of CREB and SP1 transcription factors. Oncogene 18:4108-4119.
29. Marks, P., R. A. Rifkind, V. M. Richon, R. Breslow, T. Miller, and W. K. Kelly. 2001. Histone deacetylases and cancer: causes and therapies. Nat. Rev. Cancer 1:194-202.
30. sdi1. J. Biol. Chem. 275:6353-6359.
31. Nakano, K., T. Mizuno, Y. Sowa, T. Orita, T. Yoshino, Y. Okuyama, T. Fujita, N. Ohtani-Fujita, Y. Matsukawa, T. Tokino, H. Yamagishi, T. Oka, H. Nomura, and T. Sakai. 1997. Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line. J. Biol. Chem. 272:22199-22206.
32. Nan, X., H. H. Ng, C. A. Johnson, C. D. Laherty, B. M. Turner, R. N. Eisenman, and A. Bird. 1998. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393:386-389.
33. Ohtani-Fujita, N., T. Fujita, A. Aoike, N. E. Osifchin, P. D. Robbins, and T. Sakai. 1993. CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene. Oncogene 8:1063-1067.
34. Periyasamy, S., S. Ammanamanchi, M. P. Tillekeratne, and M. G. Brattain. 2000. Repression of transforming growth factor-beta receptor type I promoter expression by Sp1 deficiency. Oncogene 19:4660-4667.
35. Plass, C., and P. D. Soloway. 2002. DNA methylation, imprinting, and cancer. Eur. J. Hum. Genet. 10:6-16.
36. Rajgolikar, G., K. K. Chan, and H. C. Wang. 1998. Effects of a novel antitumor depsipeptide, FR901228, on human breast cancer cells. Breast Cancer Res. Treat. 51:29-38.
37. Robertson, K. D., S. Ait-Si-Ali, T. Yokochi, P. A. Wade, P. L. Jones, and A. P. Wolffe. 2000. DNMT1 forms a complex with Rb, E2F1, and HDAC1, and represses transcription from E2F-responsive promoters. Nat. Genet. 25:338-342.
38. Robertson, K. D., and P. A. Jones. 2000. DNA methylation: past, present, and future directions. Carcinogenesis 21:461-467.
39. CIP1/WAF1/SDI1 gene and confers poor prognosis in acute lymphoblastic leukemia. Blood 99:2291-2296.
40. Rountree, M. R., K. E. Bachman, and S. B. Baylin. 2000. DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci. Nat. Genet. 25:269-277.
41. Rountree, M. R., K. E. Bachman, J. G. Herman, and S. B. Baylin. 2001. DNA methylation, chromatin inheritance, and cancer. Oncogene 20:3156-3165.
42. Sherr, C. J. 2000. The Pezcoller lecture: cancer cell cycles revisited. Cancer Res. 60:3689-3695.
43. Shin, J. Y., H. S. Kim, J. Park, J. B. Park, and J. Y. Lee. 2000. Mechanism for inactivation of the KIP family cyclin-dependent kinase inhibitor genes in gastric cancer cells. Cancer Res. 60:262-265.
44. WAF1 mutations and human malignancies. Leuk. Lymphoma 26:35-41.
45. Shuman, S., and J. Turner. 1993. Site-specific interaction of vaccinia virus topoisomerase I with base and sugar moieties in duplex DNA. J. Biol. Chem. 268:18943-18950.
46. Sowa, Y., T. Orita, S. Minamikawa-Hiranabe, T. Mizuno, H. Nomura, and T. Sakai. 1999. Sp3, but not Sp1, mediates the transcriptional activation of the p21/WAF1/Cip1 gene promoter by histone deacetylase inhibitor. Cancer Res. 59:4266-4270.
47. Struhl, K. 1998. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 12:599-606.
48. Sun, S., E. S. Stoflet, J. G. Cogan, A. R. Strauch, and M. J. Getz. 1995. Negative regulation of the vascular smooth muscle alpha-actin gene in fibroblasts and myoblasts: disruption of enhancer function by sequence-specific single-stranded-DNA-binding proteins. Mol. Cell. Biol. 15:2429-2436.
49. Tate, P. H., and A. P. Bird. 1993. Effects of DNA methylation on DNA-binding proteins and gene expression. Curr. Opin. Genet. Dev. 3:226-231.
50. Wade, P. A., P. L. Jones, D. Vermaak, G. J. Veenstra, A. Imhof, T. Sera, C. Tse, H. Ge, Y. B. Shi, J. C. Hansen, and A. P. Wolffe. 1998. Histone deacetylase directs the dominant silencing of transcription in chromatin: association with MeCP2 and the Mi-2 chromodomain SWI/SNF ATPase. Cold Spring Harbor Symp. Quant. Biol. 63:435-445.
51. waf1/cip1 promoter activation induced by histone deacetylase inhibitor. J. Biol. Chem. 275:1371-1376.
52. Xiong, Z., and P. W. Laird. 1997. COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res. 25:2532-2534.
53. Young, J. I., and J. R. Smith. 2001. DNA methyltransferase inhibition in normal human fibroblasts induces a p21-dependent cell cycle withdrawal. J. Biol. Chem. 276:19610-19616.
54. Zhang, Y., H. H. Ng, H. Erdjument-Bromage, P. Tempst, A. Bird, and D. Reinberg. 1999. Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev. 13:1924-1935.
55. Zhu, W. G., Z. Dai, H. Ding, K. Srinivasan, J. Hall, W. Duan, M. A. Villalona-Calero, C. Plass, and G. A. Otterson. 2001. Increased expression of unmethylated CDKN2D by 5-aza-2′-deoxycytidine in human lung cancer cells. Oncogene 20:7787-7796.
56. Zhu, W. G., R. R. Lakshmanan, M. D. Beal, and G. A. Otterson. 2001. DNA methyltransferase inhibition enhances apoptosis induced by histone deacetylase inhibitors. Cancer Res. 61:1327-1333.